Biomarkers of inflammation and risk of adverse events in patients with cirrhosis
Inflammatory biomarkers effectively identify high-risk patients with AKI and cirrhosis. Incorporating these biomarkers into clinical decision-making has the potential to guide treatment.
Authors
- Justin M. Belcher (ORCID: https://orcid.org/0000-0002-4599-8850)
- Jeremy Puthumana (ORCID: https://orcid.org/0000-0003-2033-6815)
- Wassim Obeid (ORCID: https://orcid.org/0000-0002-6054-411X)
- Joachim H. Ix
- Guadalupe Garcia-Tsao
- Arun J. Sanyal
- Chirag R. Parikh
Institutions
- Johns Hopkins University (US)
- Virginia Commonwealth University (US)
- Yale University (US)
- University of California San Diego (US)
- VA Connecticut Healthcare System (US)
- VA San Diego Healthcare System (US)
Publication Details
- Journal
- Liver Transplantation
- Published
- 2026-03-27
- DOI
- https://doi.org/10.1097/lvt.0000000000000862
- Primary Topic
- Liver Disease and Transplantation
- Type
- article
- Field-Weighted Citation Impact
- 0.00